论文部分内容阅读
[目的]探讨酒石酸美托洛尔联合稳心颗粒治疗AF的疗效。[方法]98例AF随机分为对照组(常规治疗加服酒石酸美托洛尔50～100mg/d,分2～3次口服)及治疗组(对照组治疗的基础上加服稳心颗粒每次1包(9g),3次/日)。[结果]治疗组的疗效优于对照组(χ2=5.26,P﹤0.05)。治疗组发生缺血性脑卒中的总发生率低于对照组,但差异无统计学意义(χ2=3.37,P﹥0.05)。[结论]洒石酸美托洛尔联合稳心颗粒治疗对AF具有较好的疗效。
[Objective] To investigate the curative effect of metoprolol tartrate combined with Wenxin granule in the treatment of AF. [Method] A total of 98 cases of AF were randomly divided into control group (conventional treatment plus metoprolol tartrate 50 ~ 100mg / d, 2 to 3 times orally) and treatment group (control group based on the treatment plus plus heart particles Times a packet (9g), 3 times / day). [Result] The curative effect of the treatment group was better than that of the control group (χ2 = 5.26, P <0.05). The incidence of ischemic stroke in the treatment group was lower than that in the control group, but the difference was not statistically significant (χ2 = 3.37, P> 0.05). [Conclusion] metoprolol tartrate combined with Wenxin Granule has good effect on AF.